Alleviatory effects of Danshen, Salvianolic acid A and Salvianolic acid B on PC12 neuronal cells and Drosophila melanogaster model of Alzheimer's disease.

pharmacology and toxicology view on bioRxiv

By Florence Hui Ping Tan, Andrew Chung Jie Ting, Nazalan Najimudin, Nobumoto Watanabe, Ghows Azzam

Posted 14 May 2020
bioRxiv DOI: 10.1101/2020.05.12.089797

Alzheimer's disease (AD) is the most common form of neurodegenerative disorder worldwide. Its pathogenesis involves the hallmark aggregation of amyloid-beta (Aβ). Of all the Aβ oligomers formed in the brain, Aβ42 has been found to be the most toxic and aggressive. Despite this, the mechanism behind this disease remains elusive. With the ability to utilize various genetic manipulations, Drosophila melanogaster is ideal in analysing not only cellular characteristics, but also physiological and behavioural traits of human neurodegenerative diseases. Danshen water extract (DWE), obtained from the root of Salvia miltiorrhiza Bunge, was found to have a vast array of beneficial properties. In this study, DWE, and its major components, Salvianolic acid A (SalA) and Salvianolic acid B (SalB) were tested for their abilities to ameliorate Aβ42's effects. DWE, SalA and SalB were confirmed to be able to reduce fibrillation of Aβ42. As Aβ42 causes neurodegeneration on neurons, DWE, SalA and SalB were tested on Aβ42-treated PC12 neuronal cells and were shown to increase cell viability. DWE and its components were then tested on the Drosophila melanogaster AD model and their rescue effects were further characterized. When human Aβ42 was expressed, the Drosophila exhibited degenerated eye structures known as the rough eye phenotype (REP), reduced lifespan and deteriorated locomotor ability. Administration of DWE, SalA and SalB partially reverted the REP, increased the age of AD Drosophila and improved most of the mobility of AD Drosophila . In conclusion, DWE and its components may have therapeutic potential for AD patients and possibly other forms of brain diseases. ### Competing Interest Statement The authors have declared no competing interest.

Download data

Downloaded 115 times
Download rankings, all-time:
- Site-wide: 118,134
- In pharmacology and toxicology: 975
Year to date:
- Site-wide: 115,757
Since beginning of last month:
- Site-wide: 115,757

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide

PanLingua

Multi-lingual preprint search

News

27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
22 Jan 2019: Nature just published an article about Rxivist and our data.
13 Jan 2019: The Rxivist preprint is live!